"Regulatory guidance associated with the requirements of a product’s stability testing program."
New or existing modified drug Stability Testing Program's regulations/requirements stipulated by the FDA, 21 CFR or other regulations may sometimes creating an overwhelming situation based on the type of product that is being manufactured. Hence, some manufacturers of new drug products have made inadvertent mistakes in the design of their new drug stability testing program.
- Regulatory guidance associated with the requirements of a product’s stability testing program.
- Using the Laboratory Information Management Systems (LIMS) in a Stability Study Program
- Data Documentation, Entry and Management (Types of Documentation Methods)
- The Criticality of the Choice of a Stability Test Data Management System used for Data Management.
- Considerations when choosing a Stability Test Data Management System
Timings8:00 AM - 5:00 PM (Feb 13) (General)
8:00 AM - 5:00 PM (Feb 14) (General)
Entry FeesPaid Ticket Starts from 2099 USD View Details
5 Exhibitors Estimated Count
Category & TypeConference
Medical & Pharma
Editions13 - 14 Feb 2020 Interested
15 - 16 Feb 2018 2nd Edition
23 - 24 Jun 2016 1st EditionView More
Official LinksWebsite Contacts
Claim this event
OrganizerSend Stall Book Request
ComplianceOnline USATop Rated 356 events listed
Write a ReviewAdd Your Review
Visitor Ticket Price Buy Now
|2099 USD||Attendee Seminar One Registration|
Venue Map & Directions
Venue to be announced
San Francisco, USAAdd Venue
Days Inn by Wyndham San Francis..from USD 101.99
Stanford Court San Franciscofrom USD 475.15
The Alpine Inn & Suitesfrom USD 143.99
Hyatt Place Emeryville/San Fran..from USD 197.1